Soluble complement receptor 1 (sCR1) is not as effective as Cobra Venom Factor in the treatment of Experimental Allergic Neuritis

International Journal of Neuroscience

Volumn 92, Issue 3-4, 1997, Pages 287-298

  Vriesendorp, Francine J ^a   Flynn, Robyn E ^a   Pappolla, Miguel A ^a   Koski, Carol L ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Complement; Demyelination; EAN; Macrophage; Soluble Complement Receptor 1

Indexed keywords

EID: 0031425108     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207459708986406     Document Type: Article

References (25)

1. Candinas, D., Lesnikoski, B. A., Robson, S. C , Miyatake, T., Scesney, S. M., Marsh, H. C., Ryan, U. S., Dalmao, A. P., Hancock, W. W. & Bach, F. H. (1996). "Effect of repetitive high-dose treatment with soluble complement receptor type 1 and Cobra Venom Factor on discordant xenograft survival," Transplantation, 62, 336-342.
2. Chavez-Cartaya, R. E., Pino DeSola, G., Wright, L., Jamieson, N. V. & White, D. J. G. (1995). "Regulation of the complement cascade by soluble complement receptor type 1. Protective effect in experimental liver ischemia and reperfusion," Transplantation, 59, 1047-1052.
3. Couser, W. G., Johnson, R. J., Young, B. A., Yeh, C G , Toth, C. A. & Rudolph, A. R. (1995) "The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis," Journal of the American Society of Nephrology, 5, 1888-1894.
4. Dashill, S., Vanguri, P. & Koski, C. L. (1994). "Cytokines and cyclic AMP induce C3 production in rat Schwann cells," Journal of Immunology, 150, part II, 225A
5. Dianzani, U. & Malavasi, F. (1995). "Lymphocyte adhesion to endothelium," Critical Reviews in Immunology, 15, 167-300.
6. Feasby, T. E., Gilbert, J. J., Hahn, A. F. & Neilson, M. (1987). "Complement depletion suppresses Lewis rat experimental allergic neuritis," Brain Research, 419, 97-103
7. Hafer-Macko, C. E., Sheikh, K. A , Li, C. Y , Ho, T. W., Cornblath, D. R., McKhann, G. M., Asbury, A. K. & Griffin, J W. (1996). "Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy," Annals of Neurology, 39, 625-635.
8. Hahn, A. F., Feasby, T E., Wilkie, L. & Lovgren, D. S. (1991). "P2-peptide induced experimental allergic neuritis: a model to study axonal degeneration," Acta Neuropathologica, 82, 60-65
9. Hartung, H. P., Schwenke, C., Bitter-Suermann, D. & Toyka, K. V. (1987). "Guillain-Barré syndrome activated complement components C3a and C5a in CSF," Neurology, 37, 1006-1009.
10. Hartung, H. P., Stoll, G. & Toyka, K. V. (1993) Immune reactions in the peripheral nervous system In: Dyck, P J. & Thomas, P. K., (eds) Peripheral Neuropathy, (Philadelphia, Saunders), pp 418-444.
11. Hill, J., Lindsay, T. F , Ortiz, F. Yeh, C G., Hechtman, H. B. & Moore, F. D., Jr., (1992). "Soluble complement receptor type I ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat," Journal of Immunology, 149, 1723-1728.
12. Jung, S., Toyka, K. V & Hartung, H. P. (1995). "Soluble complement receptor type 1 inhibits experimental autoimmune neuritis in Lewis rats," Neuroscience Letters, 200, 167-170.
13. Koski, C. L., Humphrey, R. & Shin, M. L (1985). "Anti-peripheral myelin antibody in patients with demyelinating neuropathy: Quantitative and kinetic determination of serum antibody by complement component 1 fixation," Procedings of the National Academy of Science USA, 82, 905-910.
14. Koski, C. L., Sanders, M. E , Swoveland, P. T., Lawley, T. J., Shin, M. L., Frank, M. M. & Joiner, K. A. (1987). "Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies," Journal of Clinical Investigation, 80, 1492-1497.
15. McPhaden, A. R. & Whaley, K. (1993). "Complement biosynthesis by mononuclear phagocytes," Immunology Research, 12, 213-232.
16. Piddlesden, S. J., Storch, M. K., Hibbs, M., Freeman, A. M., Lassmann, H & Morgan, B. P. (1994) "Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis," Journal of Immunology, 152, 5477-5484.
17. Pruitt, S. K., Kirk, A. D., Bollinger, R. R., Marsh, H. C., Jr., Collins, B. H., Levin, J L., Mault, J. R., Heinle, J. S., Ibrahim, S. & Rudolph, A. R. (1994). "The effect of soluble complement receptor 1 on hyperacute rejection of porcine xenografts," Transplantation, 57, 363-370.
18. Sanders, M. E., Koski, C. L., Robbins, D., Shin, M. L., Frank, M. M. & Joiner, K. A. (1986). "Terminal complement pathway activation in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis," Journal of Immunology, 136, 4456-4459.
19. Sawant-Mane, S , Clark, M. B. & Koski, C L (1991). "In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes," Annals of Neurology, 29, 397-404.
20. Sawant-Mane, S., Piddlesden, S. J., Morgan, B. P., Holera, V. M. & Koski, C. L. (1996). "CD 59 homologue regulates complement dependent cytolysis of rat Schwann cells," Journal of Neuroimmunology, 69, 63-71
21. Stoll, G., Schmidt, B., Jander, S , Toyka, K. V. & Hartung, H. P. (1991). "Presence of the terminal complement complex (C5b-9) precedes myelin degradation in immune-mediated demyelination of the rat peripheral nervous system," Annals of Neurology, 30, 147-155.
22. Vaporciyan, A. A., Mulligan, M S., Warren, J. S., Barton, P. A., Miyasaka, M. & Ward, P. A. (1995). "Up-regulation of lung vascular ICAM-1 in rats is complement dependent," Journal of Immunology, 155, 1442-1449.
23. Von Zabern, I. (1993). Effects of venoms of different animal species on the complement system. In: Activators and inhibitors of complement (ed.) R.B. Sim, (Kluwer Academic Publishers, The Netherlands), pp. 127-135.
24. Vriesendorp, F. J., Flynn, R. E., Pappolla, M. A. & Koski, C. L. (1995). "Complement depletion affects demyelination and inflammation m experimental autoimmune neuritis," Journal of Neuroimmunology, 58, 157-165.
25. Weisman, H. F., Bartow, T., Leppo, M. K., Marsh, H. C., Carson, G. R., Concino, M. F., Roux, K. H., Weisfeldt, M. L & Fearon, D T. (1990). "Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischaemic myocardial inflammation and necrosis," Science, 249, 146-15.